How To Use CPT Code 90621

CPT 90621 describes the administration of a meningococcal recombinant lipoprotein vaccine, specifically for serogroup B (MenB-FHbp), as part of a two or three-dose schedule. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90621?

CPT 90621 is used to describe the administration of a meningococcal recombinant lipoprotein vaccine, specifically for serogroup B (MenB-FHbp). This vaccine is given to individuals who are 10 years old and older and are at risk for meningococcal disease caused by Neisseria meningitides. The vaccine is typically administered as part of a two or three-dose schedule to provide protection against this form of meningitis and septicemia.

2. Official Description

The official description of CPT code 90621 is: ‘Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 2 or 3 dose schedule, for intramuscular use.’

3. Procedure

1. The healthcare provider prepares the patient for the administration of the meningococcal recombinant lipoprotein vaccine.
2. The provider injects the vaccine into the muscle of the upper arm, following the appropriate dosage and schedule for the patient.
3. Prior to administering the vaccine, the provider counsels the patient and/or their family, providing information on the risks, benefits, potential side effects, and precautions associated with the vaccine.
4. The provider may also provide instructions to the patient on how to manage any potential side effects or adverse reactions.
5. If necessary, the provider schedules additional doses of the vaccine to complete the recommended two or three-dose schedule.

4. Qualifying circumstances

CPT 90621 is used for individuals who are at risk for meningococcal disease caused by Neisseria meningitides. This may include individuals who are 10 years old and older and have certain medical conditions or who are in environments where the risk of exposure to the bacteria is higher, such as college dormitories or military barracks. The vaccine is administered by a healthcare provider and is part of a two or three-dose schedule to ensure optimal protection against meningococcal disease.

5. When to use CPT code 90621

CPT code 90621 should be used when a healthcare provider administers the meningococcal recombinant lipoprotein vaccine, specifically for serogroup B (MenB-FHbp), as part of a two or three-dose schedule. It is important to follow the recommended dosage and schedule for the vaccine to ensure adequate protection against meningococcal disease caused by Neisseria meningitides.

6. Documentation requirements

To support a claim for CPT code 90621, the healthcare provider must document the following information:

• The patient’s medical history and risk factors for meningococcal disease
• The specific vaccine administered (MenB-FHbp)
• The dosage and schedule of the vaccine
• The date of administration
• Counseling provided to the patient and/or their family
• Information on potential side effects, risks, benefits, and precautions
• Instructions for managing any potential side effects or adverse reactions

7. Billing guidelines

When billing for CPT code 90621, ensure that the vaccine administered is the meningococcal recombinant lipoprotein vaccine for serogroup B (MenB-FHbp). Follow the appropriate dosage and schedule for the vaccine. It is important to document the administration of the vaccine, as well as any counseling provided to the patient and/or their family. Report separate codes for vaccine administration, the actual vaccine, and any associated office visit. If the provider administers a different vaccine for serogroup B meningococcal infection, use the appropriate code (e.g., CPT code 90620).

8. Historical information

CPT code 90621 was added to the Current Procedural Terminology system on January 1, 2016. There have been no updates or changes to the code since its addition.

9. Examples

1. A healthcare provider administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a 15-year-old patient as part of a two-dose schedule.
2. A nurse administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a college student living in a dormitory as part of a three-dose schedule.
3. A pediatrician administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a 10-year-old patient with a medical condition that puts them at risk for meningococcal disease.
4. A healthcare provider administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a military personnel as part of a two-dose schedule.
5. A family physician administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a patient who will be traveling to an area with a high incidence of meningococcal disease.
6. A nurse administers the meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), to a patient who has had close contact with an individual diagnosed with meningococcal disease.